Partnering with Pharma to Conduct Research and Create Novel Therapies
Samsung Developer
Advancements in medical research and technology are transforming the pharmaceutical industry by accelerating drug development, enabling personalized medicine, and enhancing patient care through AI, big data, and advanced diagnostics.
Samsung Health collects and analyzes valuable health data from users’ daily activities. Using sensors in Galaxy smartphones and wearables, it tracks fitness activities, sleep cycles, nutrition, and more. When combined, this data offers a comprehensive, data-driven view of an individual’s overall health. When studied in depth, these insights can serve as a crucial resource for researchers, helping them better understand health conditions and explore how pharmaceutical interventions can improve wellness.
One key area of study is sleep disturbances, a common and disruptive symptom among menopausal women. However, the causes of these disturbances remain insufficiently understood, and existing sleep aids often prove ineffective. To bridge this knowledge gap, Samsung Health has partnered with Bayer to conduct an observational study on sleep disturbances in menopausal women.
With access to one of the world’s largest collections of biometric data from wearable devices, Samsung is uniquely positioned to enhance research in women's health with real-world evidence. By analyzing sleep patterns, heart rate variability, and overall well-being, Samsung Health can help Bayer gain deeper insights into women's health, enabling the development of targeted and meaningful treatment options at various life stages. This research aims to expand treatment options and improve sleep solutions for those experiencing menopause-related sleep issues.
Technology plays a vital role in advancing clinical studies and medical research by providing real-time data and analytics from everyday activities, ultimately shaping better health outcomes.
